Impilo Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Impilo has acquired 4 companies.

Impilo’s most common sectors for investment are medical products (34%) and business services (17%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (67%) and secondary buyout (34%). In total, Impilo has invested in 4 different countries.

Join Mergr to view Impilo’s full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity6
  • Total Sectors Invested 5
  • Total Countries Invested 4

Impilo

Holländargatan 20,
Stockholm, SE-111 60
Sweden
+46 8 401 00 60
www.impilo.se
info@impilo.se

Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: Scandinavia

Transaction Criteria Min Max
Target Revenue 200 1,500
Target EBITDA - -
Investment Size 100 1,000
Enterprise Value - -
values in millions of SEK

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.2/yr) # - 2 1 3 - - 6
Sell (0.0/yr) # - - - - - - 0
  6

Most Recent M&A

Company Date Value Type
Euro Accident Livförsäkring AB 2019-09-03 - Buyout (LBO, MBO, MBI)
Danderyd, Sweden · www.euroaccident.se
The Fertility Partnership 2019-03-28 - Secondary Buyout
Oxford, United Kingdom · www.thefertilitypartnership.com
Humana AB 2019-01-14 - Secondary Buyout
Stockholm, Sweden · www.humana.se
Immedica Pharma AB 2018-07-30 - Buyout (LBO, MBO, MBI)
Stockholm, Sweden · www.immedica.com
NutraQ AS 2017-12-01 - Buyout (LBO, MBO, MBI)
Oslo, Norway · www.nutraq.com
Ferrosan Medical Devices AS 2017-07-07 - Buyout (LBO, MBO, MBI)
Soborg, Denmark · www.ferrosanmedicaldevices.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
The Fertility Partnership 2019-03-28 VivaNeo Deutschland GmbH 2019-07-11 1
Oxford, United Kingdom · www.thefertilitypartnership.com Frankfurt, Germany · www.vivaneo-ivf.com

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 2 (33%) - 2 (33%) -
Business Services 1 (17%) - 1 (17%) -
Healthcare Services 1 (17%) - 1 (17%) -
Insurance 1 (17%) - 1 (17%) -
Life Science 1 (17%) - 1 (17%) -
Total 6 - 6 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Sweden 3 (50%) - 3 (50%) -
United Kingdom 1 (17%) - 1 (17%) -
Denmark 1 (17%) - 1 (17%) -
Norway 1 (17%) - 1 (17%) -
Total 6 - 6 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 4 (67%) - 4 (67%) -
Secondary Buyout 2 (33%) - 2 (33%) -
Total 6 - 6 -

M&A Connections

Deals
Acquired from
Investor(s)
33%
2 (33%)

Investor Summary

Size

Middle-Market

Specialist/Generalist

Specialist

Leadership

Fredrik Strömholm

Co-founder & Partner

Jesper Eliasson

Co-founder, Partner & CFO

Magnus Edlund

Partner

Veronica Byfield Sköld

Partner

Martin Fagerlund

Partner & COO

 Subscribe to unlock this and 167,062
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 156K M&A Transactions
  • 163K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 55K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal